Etienne Ntabanganyimana*, Theophile Nishimwe, Benjamin Kyavulikira, Eugene Nyandwi, Joseph Ntarindwa, Vincent Lloyd and Santosh Varughese
Volume4-Issue6
Dates: Received: 2023-06-09 | Accepted: 2023-06-15 | Published: 2023-06-16
Pages: 1043-1045
Abstract
Background: Kidney failure known as renal failure or Stage 5 CKD or End Stage Renal Diseases is a major problem among kidney diseases worldwide, its incidence and prevalence are rising yearly. The management requires renal replacement therapy, hemodialysis, 3 sessions per week or peritoneal dialysis until the time of renal transplantation. The cost is high in low income countries and is not covered by major medical insurances. Few renal patients are able to afford dialysis and renal transplantation.
Case Presentation: A 45-year-old man Butcher, living in rural Rwanda presented with renal failure and Hypertension with history of native medication intake. He remained on chronic maintenance hemodialysis since October 2017, at one to two hemodialysis sessions per month. He preserved quality of life and cognitive function. He is reporting to have more than 1000 cc of urine volume per day.
Conclusion: This case demonstrates that suboptimal hemodialysis sessions can help the renal patients to survive when they preserve residual renal functions.
FullText HTML
FullText PDF
DOI: 10.37871/jbres1766
Certificate of Publication
Copyright
© 2023 Ntabanganyimana E, et al. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Ntabanganyimana E, Nishimwe T, Kyavulikira B, Nyandwi E, Ntarindwa J, Lloyd V, Varughese S. Can a Kidney Failure Patient Survive with One to Two Hemodialysis Sessions per Month for More than 5 Years? 2023 June 16; 4(6): 1043-1045. doi: 10.37871/jbres1766, Article ID: JBRES1766, Available at: https://www.jelsciences.com/articles/jbres1766.pdf
Subject area(s)
References
- Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005 Dec;20(12):2587-93. doi: 10.1093/ndt/gfi159. Epub 2005 Oct 4. PMID: 16204281.
- Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014 Mar;2(3):e174-81. doi: 10.1016/S2214-109X(14)70002-6. Epub 2014 Feb 10. Erratum in: Lancet Glob Health. 2014 May;2(5):266. PMID: 25102850.
- Morgan L. A decade review: methods to improve adherence to the treatment regimen among hemodialysis patients. Nephrol Nurs J. 2000 Jun;27(3):299-304. PMID: 11249328.
- Chironda G, Ngendahayo F, Mudasumbwa G, Dushimiyimana V, Jeanne Tuyienge M, Kayitesi J, Nibagwire J, Gashumba O, Rajeswaran L, Mukamana D, Mukeshimana M, Katende G. Renal Replacement Therapy (RRT) in Rwanda: Benefits, challenges and recommendations. Rwanda Medical Journal. 2019;76(3):1-6.
- Elgendy A, Abdelsalam AI, Mansour M, Nassar MK. Can residual kidney function affect quality of life and cognitive function in hemodialysis patients? BMC Nephrol. 2022 Jul 23;23(1):263. doi: 10.1186/s12882-022-02892-7. PMID: 35870885; PMCID: PMC9308911.
- Steinwandel U, Kheirkhah H, Davies H. Residual renal function-how fast does the residual urine output function decline in the first year of haemodialysis? A scoping review. Front Nephrol. 2022;1:808909. doi: 10.3389/fneph.2021.808909.
- Cupisti A, Bolasco P, D'Alessandro C, Giannese D, Sabatino A, Fiaccadori E. Protection of Residual Renal Function and Nutritional Treatment: First Step Strategy for Reduction of Uremic Toxins in End-Stage Kidney Disease Patients. Toxins (Basel). 2021 Apr 19;13(4):289. doi: 10.3390/toxins13040289. PMID: 33921862; PMCID: PMC8073165.
